GO

Completed Projects

Back
Title: Homeopathic Treatment for Attention Deficit-Hyperactivity Disorder
Status: Completed
Topic: CORP** Pilot Study
Funding Source: Centers for Disease Control and Prevention
Funding Period: 2/03 – 8/03
Study Design: Randomized, Placebo-Controlled, Double-Blinded Pilot Study
Purpose:

To determine the safety and efficacy (effectiveness) of homeopathy for the treatment of Attention Deficit-Hyperactivity Disorder (ADHD) in children ages 6-12 years.

Further Study Details:

The study was conducted by Dr. Jennifer Jacobs at The Evergreen Center for Homeopathic Medicine in Edmonds, WA. Attention deficithyperactivity disorder is a prevalent condition affecting an estimated 4-12% of schoolaged children. The standard conventional treatments are effective at minimizing symptoms; however, these medications have some potential for addiction and abuse, and have the potential to produce notable side effects. It is believed that homeopathic medicine may offer the potential to be an effective adjuvant and perhaps alternative to conventional treatment. Forty-three children participated in this study and were assigned to one of two groups - individualized homeopathic remedy or placebo. All children received a standard homeopathic evaluation prior to beginning their treatment assignment. Outcomes of interest included attention and behavior as well as use/dose of conventional medications. The intervention lasted 18 weeks and children were evaluated at baseline (before treatment), 6, 12, and 18 weeks. The children were randomized to an intervention group or placebo group.

Findings:

This pilot study did not provide evidence to support a therapeutic effect of individually selected homeopathic remedies in children with ADHD. A therapeutic effect of the homeopathic encounter was suggested but warrants further evaluation. Future studies should be carried out over a longer period of time and should include a control group that does not receive the homeopathic consultation. Comparison to conventional stimulant medication for ADHD also should be considered.

Eligibility:

Children between the ages of 6-12 years with a diagnosis of ADHD.


Changed at: 4/19/2018 6:16 AM Changed by: Lisa Seaberg
Created at: 8/31/2010 10:31 AM Created by: Griffin Hospital